Sort
15,273 grants matching “antimicrobial resistance”
STRUCTURE OF MULTIDRUG TRANSPORTERS
$199Geoffrey A Chang · Stanford University · P41 · FY2007 · RR
STRUCTURE OF MULTIDRUG TRANSPORTERS
$184Geoffrey A Chang · Stanford University · P41 · FY2008 · RR
PEPTIDE INTERACTION MECHANISM WITH LAMELLAR LIPID BILAYERS: VARIANTS OF C3A PEPT
$184Cheryl R Kuske · Stanford University · P41 · FY2008 · RR
FLUCONAZOLE-BIOFILM MATRIX IN CANDIDA ALBICANS
$61David R Andes · University Of Wisconsin-Madison · P41 · FY2010 · RR
Host Defense Against HIV-related Pulmonary Infections
$8Judd E Shellito · Lsu Health Sciences Center · P01 · FY2009 · HL
Evolution of Salmonella in a cockroach vector
$1Jose Enrique Pietri · University Of South Dakota · R21 · FY2024 · AI
Mechanisms of cefiderocol nonsusceptibility and resistance evolution in carbapenem-resistant pathogens
$1En Huang · Univ Of Arkansas For Med Scis · R01 · FY2025 · AI
Asymptomatic Bacteriuria & Risk of Urinary Tract Infection in Renal Transplants
$1James Carter Rice · University Of Texas Med Br Galveston · R21 · FY2009 · DK
Diabetes and Tuberculosis Pilot
$1Adriana Perez · University Of Texas Hlth Sci Ctr Houston · P20 · FY2007 · MD
Development of HTS Assays for Bacterial DNA Replication
$1Charles S McHenry · University Of Colorado Denver · R01 · FY2007 · AI
Novel single-cell mass spectrometry methods to assess the role of intracellular drug concentration and metabolism in antimicrobial treatment failure
$1Laura-Isobel McCall · University Of Oklahoma · R01 · FY2023 · AI
ADVANCING INFECTIOUS DISEASES DETECTION AND RESPONSE IN INDONESIA THROUGH IMPROVING PUBLIC HEALTH LABORATORY CAPACITY
$1Achmad Farchanny Adryanto · Kementerian Kesehatan Ri · U01 · FY2023 · GH
Azithromycin in Cystic Fibrosis: Microbiologic and Functional Impact of Potent Anti-Pseudomonal Activity on Inflammation
$1Kathryn Anne Akong · University Of California, San Diego · U54 · FY2016 · HD
In situ formed microneedle-like depots for spatiotemporally controlled drug delivery
$1Mohamadmahdi Samandari · University Of Connecticut Sch Of Med/Dnt · R21 · FY2025 · EB
ADVANCING INFECTIOUS DISEASES DETECTION AND RESPONSE IN INDONESIA THROUGH IMPROVING PUBLIC HEALTH LABORATORY CAPACITY
$1Agus Suprapto · Kementerian Kesehatan Ri · U01 · FY2022 · GH
Antimicrobial catheters with cell and tissue compatibility
$1Kennard M Brunson · Polymer Exploration Group, Llc · R44 · FY2016 · DK
The development & pilot implementation of a Cas13a-based low-cost point-of-care assay for detecting Neisseria gonorrhoeae and molecular markers of antimicrobial resistance in resource-limited settings
$1Lao-Tzu Allan-Blitz · Brigham And Women'S Hospital · K23 · FY2025 · AI
Gut Microbiome and Pharmacokinetic Variability in Tuberculosis and Diabetes
$1Navaneeth Narayanan · Rutgers, The State Univ Of N.J. · K23 · FY2023 · AI
Reinforcing the barrier: Understanding how cell envelope modifications promote intrinsic antimicrobial tolerance and resistance in Acinetobacter baumannii
$1Joseph Michael Boll · University Of Texas Arlington · R35 · FY2023 · GM
Experimental human infection with isogenic mutants of Neisseria gonorrhoeae
$1Marcia Metzgar Hobbs · Univ Of North Carolina Chapel Hill · U01 · FY2019 · AI
Synthesis and Study of Medicinally Important Molecules
$1Mingji Dai · Purdue University · R35 · FY2022 · GM
Adherence mechanisms of Moraxella catarrhalis
$1Eric R Lafontaine · University Of Toledo Health Sci Campus · R01 · FY2007 · AI
Chemical Inhibitors to Define an Essential M. Tuberculosis Signaling Network
$1Robert N Husson · Boston Children'S Hospital · R01 · FY2013 · AI
Sulfur Metabolism in Human Pathogens
$1Kate Suzanne Carroll · University Of Florida · R01 · FY2024 · GM
ADVANCING INFECTIOUS DISEASES DETECTION AND RESPONSE IN INDONESIA THROUGH IMPROVING PUBLIC HEALTH LABORATORY CAPACITY
$1Agus Suprapto · Kementerian Kesehatan Ri · U01 · FY2021 · GH